Title: Amalija Narandyu: Innovator in Pharmaceutical Antibiotics
Introduction
Amalija Narandyu is a notable inventor based in Zagreb, YU. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. Her work focuses on semisynthetic derivatives that have the potential to combat bacterial infections.
Latest Patents
Amalija Narandyu holds a patent titled "Derivatives Of 10,11,12,13-Tetrahydrodesmycosin Processes For Preparation, And Use Thereof In Pharmaceuticals." This invention relates to derivatives of 10,11,12,13-tetrahydro-desmycosin, where R stands for O or (OC2H5)2, R1 stands for Si(CH3)3 or H, and R2 stands for H, OH, I, or OSO2CH3. These compounds are novel semisynthetic antibiotics of the tylosin series, possessing antibacterial activity. The patent also covers their pharmaceutically acceptable salts with inorganic or organic acids, the processes for their preparation, and their use in pharmaceutical preparations. Notably, she has 0 patents in total.
Career Highlights
Amalija Narandyu is associated with Pliva Farmaceutska Kemijska, Prehrambena I Kozmeticka Industrija S.p.o., where she has been involved in research and development of pharmaceutical products. Her innovative approach has contributed to advancements in antibiotic therapies.
Collaborations
Amalija has collaborated with her coworker, Slobodan Djokic, to further enhance her research efforts in the pharmaceutical industry.
Conclusion
Amalija Narandyu's work in developing novel antibiotics showcases her dedication to improving healthcare through innovation. Her contributions to the field of pharmaceuticals are noteworthy and reflect her commitment to advancing medical science.